Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment

scientific article

Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1012740637
P356DOI10.1186/S12974-016-0589-4
P932PMC publication ID4888657
P698PubMed publication ID27245439

P50authorMarco VincetiQ52576882
Jessica MandrioliQ57233868
P2093author name stringBerta Brodsky
Uri Wormser
Nicola Fini
Yoram Finkelstein
Amnon Sintov
Elena Proskura
P2860cites workProteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS)Q81280255
Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation?Q83169004
Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosisQ84082658
Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literatureQ30580165
Should health-care systems pay for replacement therapy in patients with alpha(1)-antitrypsin deficiency? A critical review and cost-effectiveness analysisQ33860662
Prognostic factors in ALS: A critical reviewQ36447824
Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survivalQ36602163
Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole bloodQ37159126
C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complexQ37167781
Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agentQ37986292
Inflammation and neurovascular changes in amyotrophic lateral sclerosis.Q38056551
The concentration of alpha-1-antitrypsin in cerebrospinal fluid and serum in a series of 40 intracranial tumorsQ40698530
Cerebrospinal fluid alpha-1-antitrypsin alpha-1-antitrypsin-elastase complex levels in meningitisQ44292976
Serpin=serine protease-like complexes within neurofilament conglomerates of motoneurons in amyotrophic lateral sclerosisQ46286558
Amyotrophic lateral sclerosis mortality in the United States, 1979-2001.Q46789821
Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosisQ47621315
A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.Q51864361
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.Q53388392
P433issue1
P921main subjectcerebrospinal fluidQ54196
amyotrophic lateral sclerosisQ206901
P304page(s)131
P577publication date2016-06-01
P1433published inJournal of NeuroinflammationQ15716679
P1476titleReduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment
P478volume13

Reverse relations

cites work (P2860)
Q41475139Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Q64095961Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral Sclerosis
Q46370548Elevated Levels of Selenium Species in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients with Disease-Associated Gene Mutations
Q42278003iTRAQ-Based Proteomics of Chronic Renal Failure Rats after FuShengong Decoction Treatment Reveals Haptoglobin and Alpha-1-Antitrypsin as Potential Biomarkers.

Search more.